You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 3050Biotin 721FITC 702HRP 688PE 621APC 453Cy3 418AP 417PerCP 371BF488 358PE/Cy5 358APC/Cy5.5 357APC/Cy7 357BF405 357BF647 357PE/Cy5.5 357PE/Cy7 357PerCP/Cy5.5 357BF555 356Pacific Blue 356PerCP/Cy7 356BF350 355BF594 355BF680 355BF700 355BF750 355Cy5 355Cy5.5 355RBITC 355Cy7 354IRDye800 261AE 75iFluor647 62RPE 14SureLight 488 6IRDye800CW 2MMAE 1
Biologically Active
Featured Product
Mouse PCSK9 [orb2993451]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14&58.2 KDa. Observed: 19&60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human PCSK9 [orb2993449]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 15-18&60-80 KDa. Observed: 13.8&58.2 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human PCSK9 [orb2993454]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 13.77&58.2 KDa. Observed: 19&60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Biotinylated Human PCSK9 [orb2993453]
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14&59 KDa. Observed: 19&65 KDa, reducing conditions
20 μg, 100 μg - Human ATG5 [orb2993325]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 32.4 KDa. Observed: 33 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FAS [orb2993174]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.6 KDa. Observed: 60 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μg - Cynomolgus TNFRSF10B [orb2993089]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18 KDa. Observed: 22-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse Fas [orb2994282]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.4 KDa. Observed: 25-35 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse Fas [orb2994281]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.7 KDa. Observed: 55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human TRAIL R4 [orb2994136]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.4 KDa. Observed: 50-70 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg